H.R. 8840
Fair Care Act of 2026
Sponsor: Bruce Westerman · 0 cosponsors
Official summary
No official summary yet.
Text of the bill
I Modernization of health savings accounts
A Modernization of health savings accounts and contributions
B Assistance to health savings accounts
II Improving Private Health Insurance
A Maintaining Protections for Patients with Preexisting Conditions
B Expanding Coverage Options
C Improving Commercial Health Insurance
III Competition, Transparency and Accountability
A Provider and Insurer Competition
B Price Transparency
(a) Study. Not later than 1 year after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study to—
(1) describe what is known about profit- and revenue-sharing relationships in the commercial health care markets, including those relationships that—
(A) involve one or more—
(i) physician groups that practice within a hospital included in the profit- or revenue-sharing relationship, or refer patients to such hospital;
(ii) laboratory, radiology, or pharmacy services that are delivered to privately insured patients of such hospital;
(iii) surgical services;
(iv) hospitals or group purchasing organizations; or
(v) rehabilitation or physical therapy facilities or services; and
(B) include revenue- or profit-sharing whether through a joint venture, management or professional services agreement, or other form of gain-sharing contract;
(2) describe Federal oversight of such relationships, including authorities of the Department of Health and Human Services and the Federal Trade Commission to review such relationships and their potential to increase costs for patients, and identify limitations in such oversight; and
(3) as appropriate, make recommendations to improve Federal oversight of such relationships.
(b) Report. Not later than 1 year after the date of enactment of this Act, the Comptroller General of the United States shall prepare and submit a report on the study conducted under subsection (a) to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Education and Workforce and the Committee on Energy and Commerce of the House of Representatives.
C Prescription Drug Competition and Innovation
D Prescription Drug and Pharmacy Benefit Manager Transparency
E Medicare and Medicaid Prescription Drug Reforms
F Medical Malpractice Reform
IV Medicare and Medicaid Reforms
A Medicaid Reforms
B Medicare Reforms
C Medicare Choice and Competition
D Telehealth Improvements and Expansion